The U.S. Food and Drug Administration recently approved new claims for Pfizer’s Tecnis, making it the first eye lens implant for cataract patients with the potential to improve the safety of older drivers with cataracts and the people with whom they share the road.
About 60 percent of people over age 65, and 70 percent of those over 75, have some degree of cataract development, a clouding of the lens in the eye that affects vision. Approximately 2.5 million older people undergo cataract surgery each year in the United States.
The Tecnis lens was specifically designed to improve the functional vision of cataract surgery patients. Functional vision is the ability to see objects clearly under varying levels of light and in conditions such as rain, snow, fog and at night.
According to the AAA Foundation for Traffic Safety, drivers over age 65 are more likely to be involved in car crashes than people in their 30s, 40s and 50s. Providing elderly cataract patients with improved vision is critical to their safety and to the safety of others.
“The ability of the Tecnis lens to improve functional vision sets a new standard in the treatment of...
To view and download this full PLR article, you must be logged in. Registration is completely free. Once you create your account, you will be able to browse, search & downlod from our PLR articles database of over "1,57,897+" on 1,000's of niches and 200+ categories without paying a penny. Click here to signup...
